Impaired fasting glucose association with mortality in nondiabetic patients on maintenance peritoneal dialysis

American Journal of the Medical Sciences

Volumn 341, Issue 4, 2011, Pages 312-317

  Chen, Kuan Hsing ^a,b   Lin, Ja Liang ^a,b   Hung, Cheng Chieh ^a,b   Lin Tan, Dan Tzu ^a,b   Weng, Shu Man ^a   Yen, Tzung Hai ^a,b   Hsu, Ching Wei ^a,b   Yang, Chih Wei ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Impaired fasting glucose; Maintenance peritoneal dialysis; Mortality

Indexed keywords

GLUCOSE; TRANSFERRIN;

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MORTALITY; PERITONEAL DIALYSIS;

EID: 79953221086     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318203745b     Document Type: Article

References (19)

1. Lim SC, Tai ES, Tan BY, et al. Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report. Diabetes Care 2000;23:278-82.
2. Davidson MB, Landsman PB, Alexander CM. Lowering the criterion for impaired fasting glucose will not provide clinical benefit. Diabetes Care 2003;26:3329-30. (Pubitemid 37466896)
3. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 1999;354: 617-21.
4. Levitan EB, Song Y, Ford ES, et al. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 2004;164:2147-55. (Pubitemid 39410805)
5. Khaw KT, Wareham N, Bingham S, et al. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004;141:413-20.
6. Kalantar-Zadeh K, Block G, Humphreys MH, et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003;63:793-808. (Pubitemid 36315558)
7. Lin-Tan DT, Lin JL, Wang LH, et al. Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis. J Am Soc Nephrol 2007;18:2385-91.
8. Bergstrom J, Furst P, Alvestrand A, et al. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 1993;44:1048-57. (Pubitemid 23316473)
9. Szeto CC, Chow KM, Kwan BC, et al. New-onset hyperglycemia in nondiabetic chinese patients started on peritoneal dialysis. Am J Kidney Dis 2007;49:524-32. (Pubitemid 46441605)
10. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-7.
11. Barr EL, Zimmet PZ, Welborn TA, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007;116: 151-7. (Pubitemid 47057520)
12. Wen CP, Cheng TY, Tsai SP, et al. Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan. Diabetes Care 2005; 28:2756-61. (Pubitemid 43958385)
13. Balkau B, Shipley M, Jarrett RJ, et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 1998;21:360-7.
14. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004;24:816-23. (Pubitemid 38620857)
15. Festa A, D'Agostino R Jr, Tracy RP, et al. C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study. Diabet Med 2002;19:939-43. (Pubitemid 35356920)
16. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002;106:2067-72. (Pubitemid 35192812)
17. Bavenholm PN, Efendic S. Postprandial hyperglycaemia and vascular damage-the benefits of acarbose. Diab Vasc Dis Res 2006;3:72-9. (Pubitemid 44638380)
18. Gerstein HC, Yusuf S, Bosch J, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006; 368:1096-105.
19. Edelstein SL, Knowler WC, Bain RP, et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997;46:701-10. (Pubitemid 27143390)